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A B S T R A C T
T-cell resilience is critical to the immune pathogenesis of human autoimmune arthritis. Autophagy is essential
for memory T cell generation and associated with pathogenesis in rheumatoid arthritis (RA). Our aim here was to
delineate the role and molecular mechanism of autophagy in resilience and persistence of pathogenic T cells
from autoimmune arthritis.
We demonstrated “Autophagic memory” as elevated autophagy levels in CD4+ memory T cells compared to
CD4+ naive T cells and in Jurkat Human T cell line trained with starvation stress. We then showed increased
levels of autophagy in pathogenic CD4+ T cells subsets from autoimmune arthritis patients. Using RNA-se-
quencing, transcription factor gene regulatory network and methylation analyses we identified MYC as a key
regulator of autophagic memory. We validated MYC levels using qPCR and further demonstrated that inhibiting
MYC increased autophagy. The present study proposes the novel concept of autophagic memory and suggests
that autophagic memory confers metabolic advantage to pathogenic T cells from arthritis and supports its re-
silience and long term survival. Particularly, suppression of MYC imparted the heightened autophagy levels in
pathogenic T cells. These studies have a direct translational valency as they identify autophagy and its metabolic
controllers as a novel therapeutic target.
1. Introduction
Autoimmune rheumatic diseases (RA and JIA) are characterized by
joint and tissue damage as a result of chronic inflammation and accu-
mulation of autoreactive and inflammatory T cells in the synovium
[1,2]. T cells — in particular resilient, auto-reactive, hyperactive T cells
and ineffective T-cell regulatory mechanisms— are critical contributors
to the pathophysiology of rheumatoid arthritis (RA) and juvenile idio-
pathic arthritis (JIA) [3–8]. Thus understanding the mechanisms un-
derlying long-term survival of these cells represents a key unmet sci-
entific need and could identify new therapeutic targets to resolve
inflammation.
During the first antigenic exposure, stimulated T cells rapidly pro-
liferate and expand to mount an effector response [9]. Subsequently,
the majority of effector T cells die due to apoptosis and aggregation of
protein bodies, but some survive to become long-lived memory T cells
[10]. The memory T cells can rapidly respond to encounters with a
similar antigen. The T-cell memory response is important to quickly and
effectively counteract secondary infection, but an abnormal memory
response by memory T-cell subsets against self antigens is harmful and
leads to persistent autoimmune disease [11,12]. Indeed, studies using
tetramers against self peptides suggest that auto-reactive CD4+ T cells
from patients with RA have a memory T-cell phenotype [12,13]. We
recently described a subset of CD4+ T cells, known as circulating pa-
thogenic-like lymphocytes (CPLs), which are significantly over-re-
presented in patients with active inflammatory arthritis and resistant to
biologic therapy [14]. CPLs are clonally expanded, pro-inflammatory,
antigen-experienced cells that transit through the synovial micro-
environment. Determining the competitive metabolic advantage of
these pathogenic cells in autoimmune disorders is a fundamental, yet an
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unaddressed question. A deeper insight into this question could provide
clues to the pathogenic mechanisms of the disease and potential targets
for the therapy.
We have demonstrated a higher rate of autophagy (autophagic flux)
in memory CD4+ T cells compared to naive CD4+ T cells isolated from
peripheral blood mononuclear cells (PBMCs) of healthy patients [15].
We also observed a higher rate of autophagy in CD4+ T cells from
patients with RA compared to CD4+ T cells from healthy controls [16].
Furthermore, studies in experimental mouse modal of arthritis showed
better disease outcome when autophagy was inhibited using chlor-
oquine when compared to diseased mouse injected with buffered saline.
Studies on humans and mice suggest that higher rate of autophagy is
required (an integral part of the mechanism) for long term survival of
memory CD4+ T cells or pathogenic CD4+ T cells in rheumatic dis-
eases.
Although autophagy is an essential process for generating and
maintaining memory T cells [17,18], it is unknown whether autophagy
itself is required for T-cell persistence and survival, and how autophagy
is regulated in memory cells. Here, we propose the concept of “autop-
hagic memory”— a persistence of epigenetic and genetic mechanisms
that promote the elevated autophagy level and confer a competitive
advantage for resilient, inflammatory T cells. We investigated how
autophagy is modulated in naive and antigen-experienced CD4+ T cells,
dissected the molecular mechanisms of autophagic memory using
model T-cell systems and finally evaluated autophagic memory in pa-
thogenic CD4+ T-cell subsets from patients with adult and juvenile
forms of rheumatoid arthritis.
2. Methods
2.1. Patients and healthy donors
Blood samples from patients with RA, JIA and healthy controls were
collected at Scripps Clinic, La Jolla, CA (USA), Gaslini Institute (Italy)
and SingHealth-Duke NUS Academic Medical Centre (Singapore) re-
spectively. PBMCs were prepared from EDTA-anticoagulated blood by
Ficoll gradient (GE Healthcare, Piscataway, NJ) followed by washing
with phosphate-buffered saline (PBS). Lymphocytes were suspended in
freezing media (90% FCS, 10% DMSO) and stored in liquid nitrogen
until further analysis. All protocols were approved by the Human
Subjects Committees of the SingHealth Academic Medical Centre and
Scripps Clinic. All samples were collected in compliance with the
Helsinki Declaration. Informed consent was obtained from all partici-
pating subjects donating biological material.
2.2. Mouse spleenocytes
Spleens from 5 DBA/1 mice were harvested and single cells sus-
pension was prepared. Spleenocytes were washed with PBS and re-
suspended in aliquots of 1ml freezing media (90% FBS, 10% DMSO)
and kept frozen in liquid nitrogen until further use. Spleenocytes were
thawed and rested for 4 h at 37° C before CytoID staining for autophagy
assessment.
2.3. Cell culture
The Jurkat T-cell line was obtained from American Type Culture
Collection (ATCC TIB-152) and cultured in RPMI 1640 complete media
(RPMI media plus 10% serum). Cells were maintained at 37 °C in a
humidified incubator with 5% CO2. Cells were passaged 80–90% con-
fluence for routine cell culture. For autophagy training Jurkat cells
were cultured in low serum media (RPMI media plus 2% serum). For
MYC inhibition 1058-F4(40 μM) or 10074-G5 (30 μM) inhibitors were
used. DMSO was used for control.
2.4. Autophagy assesment
Autophagy was measured using the CytoID Autophagy detection kit
(Enzo Lifescience). In brief, cells were stained with live/dead stain at
room temperature for 20min followed by CytoID dye staining along
with antibodies for T cell subsets at 37 °C for 30min. Autophagy levels
are represented as mean fluorescent intensity (MFI) of CytoID staining.
2.5. Fluorescence activated cell sorting
Memory (CD3+CD4+CD45RO+) and naive (CD3+CD4+CD45RO-)
T cells were sorted from thawed PBMCs using a FACS Aria III sorter (BD
Biosciences). CPLs (CD3+CD14-CD25-CD4+HLA-DR+) and effector T
cells (CD3+CD14-CD25-CD4+HLA-DR-) were also sorted from thawed
PBMCs isolated from patients with JIA. Dead cells were excluded with
Sytox Red (LifeTechnologies). Fluorochrome-conjugated antibodies
were purchased from BioLegend. The sorted cells were washed with
PBS and lysed in mirVana™ RNA lysis buffer (Thermo Fisher Scientific)
and frozen at −80 °C until required for RNA extraction.
2.6. RNA extraction and qPCR
RNA was extracted from cells using the mirVana Total RNA
Isolation Kit (Thermo Fisher Scientific) according to the manufacturer's
protocol. RNA was converted to cDNA using SuperScript IV Reverse
Transcriptase (Invitrogen). Real time quantitative PCR (RT-qPCR) was
performed using SYBR™ Green Master Mix (Invitrogen) on a LightCycler
480 thermocycler system (Roche). GAPDH was used as an internal
control for normalization of gene expression by delta CT method. List of
primers are included in supplementary table 3.
2.7. RNA-sequencing and methylation analysis
RNA from sorted CPLs and effector T cells, and RNA and genomic
DNA from Jurkat T cells was extracted using an AllPrep DNA/RNA/
miRNA Universal Isolation Kit (Qiagen). The RNA sequencing library
was prepared using the Nextera Smart-Seq® Kit (Clontech). Paired-end
RNA sequencing was performed on an Illumina HI-Seq platform
(Illumina). DNA methylation was analyzed using an Infinium
HumanMethylation450 BeadChip (Illumina). RNA isolated from Jurkat
cells and Teff cells from human PBMCs had RNA integrity number (RIN)
greater than 7. RIN number was not obtained for CPLs due to limited
amount of RNA obtained from sorted cells. However all the cDNA
sample were evaluated after library prep using bioanalyser, sequencing
read data was evaluated using FastQC tool. All the libraries passed the
FastQC test.
2.8. RNA-sequencing and methylation array data processing
Raw RNA-sequencing reads were mapped to the human genome
(Hg19) using STAR aligner [19] with default parameter. The counts of
reads mapped over gene features were obtained using the featureCounts
method of the Subread package [20]. Fold change was calculated in the
R statistical programming software, exactTest built in the edgeR
package and recommended for two group test was used for differential
gene expression analysis. Genes with FDR of less than 0.05 were con-
sidered significantly differentially expressed. STEM software [21] was
used for clustering temporal gene expression. For DNA methylation,
data were analyzed according to the recommended pipeline of the
Bioconductor minfi [22] package. Data were background-subtracted
and normalized in GenomeStudio (Illumina), then further processed
with subset-quantile within the array normalization, which normalizes
Infinium type I and II probes together. We excluded probes targeting
sex chromosomes sites, and we imposed a detection P-value threshold
of 0.01. The detection P value was calculated in GenomeStudio by
comparing the signal intensity (methylated probe
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intensity + unmethylated probe intensity) of a given CpG-targeting
probe with the signal intensity of negative control probes. The methy-
lation levels (β), which ranged from 0 (totally unmethylated) to 1
(completely methylated), were calculated for each CpG site R minfi
package.
2.9. Network analysis
A global network of transcription factors and their target genes was
created using the Encode ChIP-seq data, as previously described [23].
Using the list of differentially expressed genes (log2 fold-change>1), a
sub-network of the global TF–gene network was created and centrality
scores for nodes were calculated using both the PageRank and be-
tweeness centrality algorithms in the Python NetworkX library. The
network was visualized using Cytoscape software [24] and betweeness
centrality scores were used to define the radius of the nodes (re-
presented as circles in the network).
2.10. Statistical data analysis
Statistical analyses of qPCR and CytoID data were performed using
GraphPad Prism software. Data are presented as the means ± standard
error of the mean. A P value < 0.05 was considered statistically sig-
nificant.
3. Results
3.1. Naive and memory CD4+ T cells from patients with RA exhibit
heightened autophagy
T cells that have experienced activation exhibit higher autophagic
flux compared to naive T cells [15]. We hypothesized that higher levels
of autophagy activation could be particularly relevant in T cells ex-
periencing chronic pro-inflammatory stimuli, present in autoimmune
diseases, as compared to T cells from healthy individuals which are not
exposed to a chronic inflammatory environment. We evaluated the ef-
fects of T-cell receptor (TCR) activation in memory and naive CD4+ T
cells, using T cells isolated from patients with RA and healthy subjects.
Fluorescence-activated cell-sorted T cells were activated with CD3+
CD28 + beads and autophagy was measured 5 days later. Consistent
with our hypothesis, autophagy levels were significantly higher in both
naive and memory CD4+ T cells from patients with RA compared to
respective cells from healthy subjects, indicating an increased baseline
level of autophagy in patients. In addition, autophagy was even higher
in memory T cells compared to naive T cells from patients with RA and
healthy subjects (Fig. 1A). Furthermore, no statistical difference in
autophagy levels were observed between the naive and memory CD4+
T cells from healthy individuals in absence of TCR stimulus or in pre-
sence of suboptimal (3 cells: 1 bead ratio) TCR stimulus (Sup Fig. 1).
These data suggest that higher autophagy is required to sustain the
effector response generated by antigen experienced memory CD4+ T
cells when they encounter secondary TCR stimulus.
Pathogenic subsets of memory T cells can be identified in patients
with RA. If autophagy is a method used by pathogenic cells to survive,
the level of autophagy in these cells should be higher when compared to
total effector T cells. We have observed a population of memory, acti-
vated, antigen experienced, pro-inflammatory T cells (CPLs), that cor-
relate with disease activity, in patients with active arthritis who are
resistant to therapy. Autophagy may be a key mechanism for resilience
and survival of CPLs. Indeed, we found that CPLs from patients with
arthritis showed significantly higher autophagic rate compared to ef-
fector CD4+T cells isolated from the same patients (Fig. 1B). These
data further substantiate the relevance of autophagic memory in pa-
thogenic CD4+ T-cell subsets.
We next evaluated whether this phenomenon of elevated autop-
hagic rate in human memory CD4+ T cells is also present in mice by
measuring autophagy levels in memory and naive CD4+ T cells from
healthy mice. CD4+ memory T cells from mice spleen showed higher
autophagic rate compared to naive cells (Fig. 1C). Similar to observa-
tions in humans, CD4+ memory T cells from mice spleenocytes showed
Fig. 1. Autophagy levels in T-cell subsets. A) Peripheral blood mononuclear
cells (PBMCs) from patients with RA (n=8) and healthy subjects (n=5) were
stimulated with CD3/CD28-coated beads to activate T cells. Autophagy levels
were measured after 5 days by flow cytometry. The MFI of CytoID dye in
memory (red; CD3+CD4+CD45RO+) and naive (blue; CD3+CD4+CD45RO-)
cells represents as the level of autophagy. A Mann-Whitney test was used to
compare the means of the two groups. B) PBMCs from patients with juvenile
idiopathic arthritis patients (n= 7) were stained and autophagy was quanti-
tated as CytoID MFI levels. The MFI of CytoID dye in pathogenic CPLs (red;
CD3+CD4+CD14-CD25-HLA-DR+) and Teff (blue; CD3+CD4+CD14-CD25-
HLA-DR-) cells represents the level of autophagy. C) Spleenocytes from healthy
control mice (n= 5) were stained to measure autophagy in CD4+ memory and
naive T cells. The MFI of CytoID dye in memory (CD3+CD4+CD44+) and naive
(CD3+CD4+CD44-CD62L-) represents the level of autophagy. A Mann-Whitney
test was used to compare the means of the two groups. CPL, Circulating
Pathogenic-like Lymphocytes; MFI, mean fluorescence intensity; RA, rheuma-
toid arthritis; Teff, effector T cell. (For interpretation of the references to color
in this figure legend, the reader is referred to the Web version of this article.)
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higher autophagic rate compared to naive cells, further substantiating
autophagic memory as means of memory T cell persistence across
species.
3.2. MYC is a key regulatory gene of autophagic memory in human T cells
We next hypothesized that the increased levels of autophagy in
persistent antigen experienced, memory T-cell subsets is a part of a
competitive and long-lasting metabolic advantage, which we termed
“autophagic memory”. We used Jurkat cells as a model human T-cell
line to study the molecular mechanisms underlying autophagic
memory. Eliciting starvation-induced autophagy in this cell line al-
lowed us to evaluate the mechanisms of autophagic modulation and the
subsequent persistence of these cells over several generations. We
starved the cells in low serum conditions for 5 days and then re-cultured
these cells in complete media for an additional 5 days. These cells re-
present the “trained” cell group. These cells were then exposed to a
second starvation stimulus by incubating them in Earle's balanced salt
solution (EBSS) for 3 h. We found that pre-starved cells exposed to re-
peat starvation stimulus exhibited “autophagic memory”, as a sig-
nificantly higher level of autophagy was elicited upon a secondary ex-
posure to starvation conditions compared to non-starved control cells
exposed only to starvation when cultured in EBSS (Fig. 2A).
Pre-starved Jurkat T cells were then cultured in complete media for
an additional 100 days. As a Control, non-starved cells were cultured in
complete media for 100 days alongside pre-starved cells. Considering
one day of cellular growth and division as one generation, the cells at
generation 5, 30, 70 and 100 (days after 5 days pre-starvation training)
were harvested for transcriptome and methylome analysis by next-
generation RNA-sequencing and methylation array. Fold changes in
gene expression were calculated for pre-starved cells compared to
control cells at days 5, 30, 70 and 100. We hypothesized that some
genes contributing to autophagic memory in trained, pre-starved cells
would have their expression modulated during the learning phase and
would retain their expression pattern over several generations to affect
autophagic memory mechanisms.
We first filtered the gene list for temporal expression analysis on the
basis of FDR and fold change (FDR<0.05 and abs(log2_fold_-
change)> 1) at day 5 and then clustered the filtered genes to find those
with a similar expression pattern. After filtering, 533 genes were ex-
amined for expression pattern using Short Term Expression Miner
(STEM) software [21]. The STEM algorithm matches temporal expres-
sion of each gene with a pre-defined set of profiles to find significantly
enriched patterns. This temporal gene expression analysis found gene
enrichment in 8 out of 50 predefined profiles (Fig. 2B).
The gene expression profiles 47, 45, 5 and 11 showed initial mod-
ulation followed by stability until the 30th generation (Fig. 2B) sug-
gesting retention of the autophagic memory at the molecular level.
WIPI1, the human homologue of yeast gene ATG18, is a biomarker of
autophagosome formation. WIPI1 mRNA levels mimic autophagy levels
as measured by immunofluorescence imaging and puncta formation
[25]. In line with expression pattern of profile 47, 45, 5 and 11, we
found that WIPI mRNA expression was also stably upregulated until the
30th generation in pre-starved Jurkat cells (Sup Fig. 1A). Conversely,
profiles 16, 40 and 27 exhibited a more cyclical pattern, which is in-
dicative of genes involved in cell division.
We next performed gene set enrichment analysis using the GSEA
web tool to understand the function of the genes enriched in profiles 47,
45, 11 and 5. The enrichment for gene ontology (GO) biological process
found genes involved in the cellular stress response, signal transduc-
tion, lipid biosynthesis and lipid metabolic processes and the immune
response (Table S1). These findings suggest that metabolic repro-
gramming and modulation of the immune response are central to au-
tophagic memory.
To identify the key regulatory molecules driving autophagic
memory, a global transcription factor (TF) gene regulatory network
(TF-GRN) analysis was performed. The global networks of TFs and non-
regulatory genes were created from previously published data [23].
Briefly, experimentally validated targets for 329 TFs were obtained
from the ENCODE and HTRIdb databases to create the global TF-GRN.
This global TF-GRN comprised 21,940 genes including 329 TFs with
target information. The autophagic memory TF-GRN was created by
subsetting the global network with genes upregulated or downregulated
in pre-starved cells compared to control cells at day 5 post starvation.
After imposing the fold-change cutoff, a total of 533 genes were used to
create the TF-GRNs. Key regulatory genes were identified using cen-
trality measures within the autophagic memory network (Fig. 2C).
Betweenness centrality is a key centrality measure that reflects the in-
teractions between a node with all other nodes of the network, and
identifies the nodes that have the highest control over the network [26].
In our dataset, the betweenness centrality score was highest for MYC
followed by EGR1 and JUND.
We also calculated the “PageRank” score for all nodes in the net-
work. PageRank is another centrality measure used by the Google
search engine to rank a given web page [27]. The PageRank algorithm
uses the degree of connection to and from a node to rank the node.
Again, MYC followed by EGR1 and JUND achieved the highest Pa-
geRank score (Fig. 2D), confirming a possible regulatory role for these
genes. From these network analyses, we propose that MYC is a potential
hub and key driver of the autophagic memory network. Concordant
results using two methods to measure centrality substantiate the finding
that MYC is central regulator of autophagic memory.
Progressive downregulation of MYC mRNA expression in Jurkat T
cells was observed until the 30th generation, even after placing the cells
in normal, serum-containing media compared to non-starved control
cells (Fig. 2E). This finding led us to investigate whether MYC tran-
scriptional suppression is mediated at the epigenetic level. Conse-
quently, we cultured pre-starved Jurkat T cells in normal media for 100
generations along with control cells and harvested them at days 5, 30,
70 and 100 for DNA methylation analysis.
We specifically looked for DNA methylation at MYC CpG regulatory
sites and found hypermethylation in 5/7 sites (Fig. 2F). Three of these
sites remained hypermethylated until the 30th generation and were
negatively correlated with the MYC RNA level (Fig. 2F). DNA methy-
lation in genetic regulatory regions is associated with transcriptional
inactivation [28–30]. These data suggest that MYC is epigenetically
suppressed in cells that maintain autophagic memory. This epigenetic
modification may contribute to the molecular mechanisms of autop-
hagic memory in pre-starved, trained Jurkat cells to the 30th genera-
tion.
3.3. MYC helps retain autophagic memory and resilience of pathogenic
human CD4+ memory T cells (CPL) in autoimmune arthritis
To extend and validate the observation that MYC is a key regulator
of autophagic memory, we analyzed the transcriptome of CPLs and Teff
CD4+ T cell subsets sorted from JIA patients (n=8) PBMCs. RNA-se-
quencing data from CPLs were compared with the total effector T-cell
population from the same patients. Differential gene expression analysis
found 2210 genes that were significantly modulated in a CPL versus
effector T-cell comparison. A total of 623 differentially expressed genes
(absolute (logFold change>2) were used to construct the TF-GRN of
CPLs, as described for the Jurkat T-cell TF-GRN network. As before,
betweenness centrality and PageRank scores for the CPL TF-GRN were
calculated to identify key regulators of the network. MYC received the
highest PageRank and the betweenness centrality score (Fig. 3B). Si-
milar to the autophagic memory network of Jurkat T cells, the CPL TF-
GRN is driven by the suppression of MYC (Fig. 3A).
MYC levels were further analyzed in sorted CD4+ memory and
naive T cells isolated from healthy controls (n= 5) and patients with
RA (n=11) and cells sorted from mouse spleenocytes. Consistent with
the data derived from serum starved Jurkat T cells and pathogenic CPLs
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from JIA patients, we found MYC expressed at lower levels in human
CD4+ memory T cells compared to naive CD4+ T cells from healthy
subjects (Fig. 3D) and patients with RA (Fig. 3E). CD4+ memory cells
from mice also had lower MYC expression compared to naive CD4+ T
cells (Fig. 3C) further emphasising the role of MYC as a key regulator in
retaining autophagic memory.
3.4. MYC confers the metabolic advantage to pathogenic and stress induced
T cells by regulating the glycolysis and fatty acid synthesis pathway genes
MYC is known to modulate the metabolic programming in T cells
(36). We analyzed gene of glycolysis and fatty acid synthesis pathway
in stress induced trained Jurkat cells and CPLs from patients with JIA.
The starvation-induced trained Jurkat T cells showed suppressed MYC
expression, and suppression of genes associated with glycolysis (Fig. S2
B); conversely, genes associated with fatty-acid synthesis and choles-
terol metabolism were up-regulated (Fig. S3). RNA-sequencing data
from CPLs also showed up regulation of fatty acid synthase (FASN) and
carnitine palmitoyltransferase 1A (CPT1A), two key genes of fatty acid
synthesis pathway (Fig. S4 A). However, key genes of the glycolysis
pathways, including HK1, GLUT1, PFKFB3 and ENO1 did not show any
change in expression in CPLs compared to the effector CD4+ T-cell
population (Fig. S4 B). RNA-sequencing results were also validated by
qPCR for key genes in glycolysis and fatty acid synthesis pathway in-
cluding the MYC gene expression from jurkat cells (Fig. S5). Out of 12
genes validated, expression of 9 genes (MYC, ALDOA, GPI, HK2, PFKP,
CPT1A, ACSL4, FASN, PLA2G6) were significantly (p < 0.05) different
between the pre-starved and control jurkat cells while 3 genes (SCD,
ACACA, PGK1) did not pass the statistical significance.
3.5. MYC inhibition increases autophagy
Our data from Jurkat T cells and primary CD4+ memory T cells
identify MYC as a central regulator of autophagic memory, suggesting
the hypothesis that MYC suppression leads to higher autophagy to
support memory-cell survival and persistence of pathogenic CD4+ T
cells. To confirm our findings we tested two MYC inhibitors, 10058-F4
and 10074-G5 [31], for their ability to increase autophagy levels.
Human Jurkat T cells were cultured for 18 h in the presence or absence
of these inhibitors and autophagy was measured by CytoID staining and
flow cytometry. Cells cultured in the presence of either MYC inhibitor
showed, albeit at different levels, significantly increased autophagy
levels compared to control cells (Fig. 4A). These experiments clearly
demonstrated that MYC suppression is a mechanism of enhancing au-
tophagy. We further studied whether inhibiting MYC alone mimics the
training imparted by serum starvation. We cultured the cells in pre-
sence and absence of MYC inhibitor (10074-G5) in control media (10%
serum) and 2% serum media for 5 days and further cultured these cells
for another 5 days in 10% serum containing media. After 5 days of
normalization of pretreated and control cells, we measured autophagy
levels in response to secondary stress stimulus by culturing the cells in
EBSS for 3 h. Similar to serum starved trained cells autophagy levels
were higher in cells pretreated with MYC inhibitor (Fig. 4B). These
results further substantiate the role of MYC in regulating autophagic
memory.
4. Discussion
In the present study, we propose the concept of “autophagic
memory”, which we define as the ability of memory T cells to respond
to a second stimulus with a higher autophagy levels compared to the
naive cells. Higher autophagy was also observed in murine CD4+
memory T cells (Fig. 1C), which substantiates in different species the
concept that autophagic memory is a means of pathogenic T-cell sur-
vival and persistence. We also demonstrate higher autophagy levels in
CD4+ T cell subsets from patients with RA and JIA. Specifically, CPLs
from patients with JIA, as well as the naive and memory compartment
of CD4+ T cells from patients with RA, exhibited higher levels of au-
tophagy compared to Teff from JIA, naive and memory cells from
healthy control subjects (Fig. 1A and B). This increase in autophagy
probably contributes to the persistence and survival of inflammatory
pathogenic cells in affected patients. Previous study, using TCR se-
quence genotyping, have shown that CPLs are identical to synovial T
cells from inflamed joints of the patients and they associate with disease
activity [14]. Significantly higher autophagy in CPLs suggests that
heighten autophagy is required not only for circulating pro in-
flammatory cells but also for persistent cells, more specific to site of
inflammation. Classical CD4+ memory T cells are primarily defined by
their ability to produce cytokines and expand rapidly in response to
recall antigen exposure. Our findings suggest that autophagic memory
can be added to the functional repertoire of memory T cells. Memory T
and memory B cells shares the transcriptional programme with long
term hematopoetic stem cells [32]. Various mouse and human studies,
focused on CD8+ T cells, have shown the essential role of autophagy in
memory T cell generation and maintenance [17,18]. The autophagic
memory could be a mechanism of survival for other cells including
memory CD8+ T cell subsets, memory B cells and the immune subsets
that tend to persist in other chronic inflammatory disease. However,
further investigation is required to evaluate autophagic memory in
other longer lasting cells or persistent inflammatory cells in other
chronic inflammatory diseases.
Previous studies have shown persistence of pathogenic CD4+ T cells
subsets in RA [33,34] but the molecular mechanisms underlying the
resilience of these pathogenic subsets are unknown. The complexity of
functional subtypes within the CD4+ T cell compartment [35] has
likely affected data interpretation to understand these molecular me-
chanisms. Nevertheless, studies on memory T-cell development have
suggested that epigenetic and transcriptional changes are associated
Fig. 2. MYC is a key regulator of autophagic memory in Jurkat T cells. A) Autophagy levels were measured by CytoID staining in Jurkat T cells pre-starved for 5
days (2% serum in RPMI media) or control Jurkat T cells (10% serum in RPMI media), then cultured for 5 days in complete media (10% serum in RPMI media) and
starved a second time by culturing the cells in EBSS for 3 h. Four replicate experiments were performed. The data represent the means ± standard deviation. B)
STEM analysis of differentially expressed genes in pre-starved versus control Jurkat T cells clustered the genes with similar temporal expression profiles. The time
courses for the significantly enriched profiles (based on permutation test built in the STEM software) are shown in the colored boxes along the top row (right), with
the number in the box corresponding to the profile number. The table (left) shows the number of genes clustered in each respective profile. C) Network of
transcription factors and their target genes that were differentially expressed in pre-starved Jurkat T cells compared to control Jurkat T cells. The betweenness
centrality score is represented by the size of the nodes. The color of the node represents the logfold change in gene expression. The sizes of the nodes (or hubs)
indicate the relative importance of the individual transcription factors within the whole gene network. D) Top five genes ranked by betweenness centrality and
PageRank score. E) mRNA expression of MYC over 100 generations in pre-starved and non starved Jurkat T cells cultured in complete media (RPMI media, 10%
serum). The logCPM values for MYC are plotted as a time-series graph. Cyan represents Jurkat T cells pre-starved and subsequently cultured in normal, complete
media; red represents control Jurkat T cells cultured in normal, complete media. F) 5 of the 7 MYC regulatory regions demonstrated increased DNA methylation at 5
days when starved samples were compared to the controls. Three of these MYC regulatory regions remained hypermethylated until the 30th generation in pre-starved
Jurkat T cells. Beta values for the methylation levels at various MYC CpG sites are plotted as a time series 1.2 fold change in beta value is considered differentially
methylated, average beta values from two replicates are plotted as time series graph. MFI, mean fluorescence intensity. (For interpretation of the references to color
in this figure legend, the reader is referred to the Web version of this article.)
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Fig. 3. MYC is a key regulator in patho-
genic cells from human arthritis. A) A
network of transcription factors and their
targets genes that are differentially ex-
pressed in pathogenic circulating patho-
genic-like lymphocytes compared to ef-
fector T cells was generated. Betweenness
centrality score is represented as the size of
the nodes. The color of the node represents
the logfold change in gene expression. B)
Top five genes ranked by betweenness
centrality and PageRank score. C) Memory
and naive CD4+ T cells were sorted from
mice spleenocytes (n= 5). A SYBR™ green-
based quantitative PCR assay was used to
calculate MYC gene expression in sorted
cells. MYC expression was normalized to
GAPDH and the relative expression values
are represented as arbitrary units. A Mann-
Whitney test was used to compare the
means of the two groups. The bar graph
shows MYC expression in naive and
memory CD4+ T cells from mice spleeno-
cytes. D) MYC expression in naive and
memory CD4+ T cells sorted from periph-
eral blood mononuclear cells isolated from
healthy human individuals (n= 5). E) MYC
expression in naive and memory CD4+ T
cells sorted from peripheral blood mono-
nuclear cells isolated from patients with RA
(n= 11). (For interpretation of the refer-
ences to color in this figure legend, the
reader is referred to the Web version of this
article.)
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with memory T-cell persistence [36–38]. Here, we used a human T-cell
line (Jurkat T cell) as a model system to investigate molecular me-
chanism of autophagic memory. By performing a temporal follow-up of
transcriptome of “trained” cells (pre-exposed to a starvation stimulus),
we were able to identify a transcriptional profile specific to autophagic
memory.
By integrating the transcriptional profile of our model T-cells (533
genes differentially regulated in pre-starved vs non-starved Jurkat cells)
with ENCODE CHIP-sequencing data, we identified MYC as a potential
key regulator of autophagic memory. Transcriptome analysis of pa-
thogenic CPL from JIA confirmed MYC as key regulator gene that
contributes to heighten autophagic levels. MYC was suppressed at
transcriptional level in both the trained Jurkat T cell line and in pa-
thogenic CPLs. Furthermore, we also validated that MYC is suppressed
in CD4+ memory T cells from RA and healthy individuals (Fig. 3B and
C). MYC is a known oncogene that stimulates proliferation and cellular
growth and is essential for memory T cell generation. In contrast, we
found that suppression of MYC is required for persistence and long term
survival of pathogenic and memory CD4+ T cells. Importantly, we show
here that inhibition of MYC transcriptional activity increases autophagy
(Fig. 4), which further substantiated our finding that MYC suppression
is central to autophagic memory and long term persistence. Our data
suggest that MYC might be regulated differently and specifically during
generation, contraction and maintenance phase of memory T cell life-
cycle.
MYC regulates metabolic reprogramming during T-cell activation
[39] and functions as both a transcriptional activator and repressor
[40]. Upregulation of fatty acid synthesis genes in pathogenic T cells
from JIA and pre-starved modal T-cell line suggest that perhaps
pathway pertaining to fatty acid synthesis are more relevant to autop-
hagic memory and long term persistence. The genes of the fatty acid
synthesis pathway could be prioritised as therapeutic targets for ma-
nipulating the autophagic process in pathogenic T cells from in-
flammatory rheumatic diseases.
A mechanism of direct transcriptional activation of glycolytic genes
by MYC has been demonstrated in previous reports [39,41]. By con-
trast, how and whether MYC (alone or in coordination with other fac-
tors) controls fatty-acid synthesis genes needs to be investigated. MYC
is also a well-known oncogene and is deregulated in many human
cancers. MYC induces cellular proliferation and growth, causing the
tumorigenesis [42] and thus MYC inhibitors have been well-studied and
are reported to have anti-tumor effects [43,44]. Given the oncogenic
role of MYC, direct MYC activators might not be suitable for clinical
utility in RA, due to adverse cancerous effects, but genes regulated by
MYC could be potential targets. Inhibiting genes in the fatty acid
synthesis pathway could also be a therapeutic strategy to inhibit au-
tophagic memory in persistent, pathogenic T cells.
5. Conclusions
In summary, we have demonstrated the phenomenon of autophagic
memory in CD4+ memory T cells in RA and JIA. We propose that au-
tophagic memory is a mechanism employed by pathogenic CD4+ T cell
subsets (CPLs and memory T cells) to increase resilience. Using the
Jurkat T-cell line to monitor autophagic learning, we identified MYC as
a key regulator of the autophagic memory and we validated these data
in human CD4+ T-cell subsets. Collectively, our data suggest that au-
tophagic memory is a key process mediating long-term persistence of
memory cells, in particular arthritis-specific CD4+ T cells and T-cell
subsets. We believe that these findings have direct translational im-
plications, as therapeutics directly targeting autophagy or indirectly
manipulating MYC could improve treatment outcomes for patients with
rheumatoid arthritis and juvenile rheumatoid arthritis.
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